Blog
RSS FeedPosted by Michael Wonder on 01 Dec 2016
CADTH publishes initial recommendation for Venclexta (venetoclax)
1 December 2016 - The outcome relates to the use of venetoclax for the treatment of patients with chronic lymphocytic ...
Posted by Michael Wonder on 24 Nov 2016
CADTH issues second final recommendation for Ibrance (palbociclib)
21 November 2016 - CADTH has published a final outcome for palbociclib following a resubmission from Pfizer. ...
Posted by Michael Wonder on 17 Nov 2016
Exciting new MAESTrO feature
18 November 2016 - Users can now develop and export images within the application. ...
Posted by Michael Wonder on 14 Nov 2016
Too much chemotherapy
10 November 2016 - People with cancer are living longer now than 40 years ago. This is clearly good news. But ...
Posted by Michael Wonder on 11 Oct 2016
Breast cancer chemotherapy costs vary despite similar effectiveness
11 October 2016 - Chemotherapy regimens for breast cancer can vary wildly in price even when they are comparable in ...
Posted by Michael Wonder on 04 Oct 2016
As world embraces precision medicine, Canada falls behind
4 October 2016 - The United States is going to analyze the genetic information of more than one million Americans. The ...
Posted by Michael Wonder on 30 Sep 2016
CADTH publishes initial recommendation for Darzalex (daratumumab)
29 September 2016 - CADTH has published its initial take on the reimbursement of Darzalex for patients with multiple myeloma. ...
Posted by Michael Wonder on 29 Sep 2016
CADTH issues final recommendation for Lynparza
29 September 2016 - CADTH has published its final outcome for Lynparza. ...
Posted by Michael Wonder on 29 Sep 2016
CADTH posts final recommendation for Zydelig
29 September 2016 - CADTH has published its final recommendation for Zydelig for follicular lymphoma. ...
Posted by Michael Wonder on 12 Aug 2016
CADTH issues initial pERC outcome for Lynparza (olaparib)
5 August 2016 - CADTH has published pERC's initial recommendation on the use of olaparib for use as monotherapy maintenance treatment ...
Posted by Michael Wonder on 08 Aug 2016
CADTH issues final pERC outcome for Yondelis (trabectedin)
5 August 2016 - CADTH has published pERC's final recommendation on the use of trabectedin for patients with metastatic liposarcoma ...
Posted by Michael Wonder on 21 Jul 2016
pERC issues final recommendation for Imbruvica (ibrutinib)
19 July 2016 - Canada's pCODR Expert Review Committee has issued a final recommendation for Janssen's ibrutinib for patients with ...
Posted by Michael Wonder on 30 Jun 2016
pERC issues final recommendation for cobimetinib hemifumarate (Cotellic)
30 June 2016 - The Pan Canadian Expert Review Committee has issued a final recommendation on the use of cobimetinib ...
Posted by Michael Wonder on 09 Jun 2016
Canada's health technology assessment agency gives positive recommendation for Opdivo to treat non-small cell lung cancer
8 June 2016 - Opdivo is the first immuno-oncology therapy for lung cancer in Canada to use the body’s own immune ...
Posted by Michael Wonder on 04 Jun 2016
CADTH issues final recommendation for nivolumab (Opdivo) for use in patients with non-small-cell lung cancer
3 June 2016 - Final recommendation is conditional on cost-effectivness being improved to an acceptable level. ...